Related Experiment Video
Updated: Jun 27, 2026
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
Molecular structural basis for polymorphism in Alzheimer's beta-amyloid fibrils
Anant K Paravastu1, Richard D Leapman, Wai-Ming Yau
1Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0520, USA.
Summary
Researchers developed a structural model for Alzheimer's disease amyloid fibrils (Abeta(1-40)) using NMR and microscopy. This model explains the twisted fibril structure and its threefold symmetry, offering insights into amyloid polymorphism.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Alzheimer's disease is linked to amyloid fibrils formed by beta-amyloid peptides.
- Amyloid fibril structure is crucial for understanding disease mechanisms.
- Polymorphism in amyloid structures contributes to disease variability.
Purpose of the Study:
- To determine a full structural model for Abeta(1-40) fibrils with a specific twisted morphology.
- To elucidate the molecular basis for fibril polymorphism by comparing different structures.
- To explore the general implications of structural variations in amyloid fibrils.
Main Methods:
- Solid-state Nuclear Magnetic Resonance (NMR) spectroscopy.
- Transmission Electron Microscopy (TEM).
- Mass-per-length analysis.
Main Results:
- A structural model for periodically twisted Abeta(1-40) fibrils was established.
- The model reveals threefold symmetry and specific quaternary contacts.
- Comparison with striated ribbon morphology highlights differences in symmetry and segment conformation, explaining polymorphism.
Conclusions:
- The study provides a detailed structural model for a specific Abeta(1-40) fibril morphology.
- Structural differences, including symmetry and segment conformation, underlie fibril polymorphism.
- Observed variations in fibril morphology may have broad implications for other amyloid-associated diseases.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...